Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose versus high-dose hydrocortisone replacement in secondary adrenal insufficiency
2011-000864-82Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydrocortisone in Adrenocorticotropic hormone (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Cognitive performance. Started Nov 2011; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Adrenocorticotropic hormone
Beyond the preview
Go deeper on 2011-000864-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000864-82.